Back to Authors

Schellenberg, Gerard D.

https://orcid.org/0000-0003-1115-2475

Mayo Clinic

University of Pennsylvania

Citations 21

Effects of Apolipoprotein E-ε4 and -ε2 in Amnestic Mild Cognitive Impairment and Dementia in Shanghai: SCOBHI-P
Borenstein, Amy R., Mortimer, James A., Ding, Ding , Schellenberg, Gerard D. , DeCarli, Charles, Copenhaver, Cathleen, Guo, Qihao , Chu, Shugang, Salmon, David P. , Wu, Yougui , Petersen, Ronald C. , Hong, Zhen , DeCarli, Charles , Ding, Ding , Zhao, Qianhua , Galasko, Douglas , Dai, Qi , DeCarli, Charles

American Journal of Alzheimer's Disease & Other Dementias® | February 8, 2010 | Volume: 25 | Issue: 3 | Pages: 233-238

10.1177/1533317509357736 Get It

Objective: To determine apolipoprotein E (APOE)-ε4 and -ε2 frequencies and risk of mild cognitive impairment (MCI) and dementia in Shanghai, China. Methods: A total of 34 MCI and 34 dementia cases were recruited from an urban Memory Disorders Clinic and 32 controls were recruited from a residential community served by the clinic. Apolipoprotein E was genotyped using standard methods. Results: Among controls, frequencies were ε2, 0.11; ε3, 0.84; and ε4, 0.05; among MCI, 0.05, 0.77, and 0.18; and for dementia, 0.02, 0.84, and 0.15, respectively. In education-adjusted models, the odds ratio (OR) = 5.6 for dementia (95% CI = 1.09-29.3) and 4.7 for MCI (95% CI = 0.90-25.2) associated with any ε4 allele. The ε2 allele was inversely associated with dementia (OR = 0.12, 95% CI = 0.013-0.997) and MCI (OR = 0.38, 95% CI = 0.08-1.61). Conclusions: APOE-ε4 increases and -ε2 decreases the risk of dementia vs normal cognition. Similar trends were observed for amnestic mild cognitive impairment (aMCI).